Seelos Therapeutics, Inc.
SEELDelisted Apr 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001017491
Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Seelos Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −12 vs. Q3 2021
- Shares held
- 40.5M
- −245.1K (−0.6%) vs. Q3 2021
- Total value
- $65.9M
- −$32.1M (−32.8%) vs. Q3 2021
- New holders
- 11
- 37 more added
- Sold out
- 23
- 23 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SEEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 3 | $4.77K |
| Q3 2024 | 15 | $145.2K |
| Q2 2024 | 23 | $129.4K |
| Q1 2024 | 36 | $1.55M |
| Q4 2023 | 39 | $2.48M |
| Q3 2023 | 82 | $7.01M |
| Q2 2023 | 83 | $27.1M |
| Q1 2023 | 80 | $15.1M |
| Q4 2022 | 80 | $15.6M |
| Q3 2022 | 85 | $28.0M |
| Q2 2022 | 86 | $21.3M |
| Q1 2022 | 92 | $33.0M |
| Q4 2021 | 97 | $65.9M |
| Q3 2021 | 110 | $98.2M |
| Q2 2021 | 105 | $107.8M |
| Q1 2021 | 73 | $124.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Seelos Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −158,278−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −114,729−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −98,157−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −89,297−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −80,998−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −63,972−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −54,000−100.0% | Sold out |
| Alpha Paradigm Partners, LLC | 0 | $0 | 0.00% | −51,791−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −29,690−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −29,200−100.0% | Sold out |
| Hollencrest Capital Management | 0 | $0 | 0.00% | −22,600−100.0% | Sold out |
| Sovereign Financial Group, Inc. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −18,722−100.0% | Sold out |
| Williams Jones Wealth Management, LLC. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Better Money Decisions, LLC | 0 | $0 | 0.00% | −2,862−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −501−100.0% | Sold out |
| Sargent Bickham Lagudis LLC | 0 | $0 | 0.00% | −345−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −253−100.0% | Sold out |
| Knott David M | – | – | – | – | Not filed |